三七总皂苷预防髋关节置换术后深静脉血栓形成的Meta分析

doi:10.3969/j.issn.1006-5253.2018.02.002

Abstract
Figure/Table
References
Related Citation (4)

Download: PDF (1398 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To systematically evaluate the efficacy of Panax Notoginseng Saponins for deep venous thrombosis (DVT) in hip arthroplasty. Methods Randomized controlled trials and screening study of Panax Notoginseng Saponins intervention study of deep venous thrombosis (DVT) in hip arthroplasty were searched with computer in the Cochrane Library, and data were extracted for analyzing research quality. And meta-analysis was performed with Revman 5.3 software. Results The decrease of incidence of deep venous thrombosis with Panax Notoginseng Saponins was not inferior to that in the control group (P>0.05), and there were no significant difference in the increase value of APTT, INR and PLT (P>0.05). While there was significant difference in the increase value of PT between two groups (P<0.05). Conclusion The decrease of incidence of deep venous thrombosis with Panax Notoginseng Saponins was not inferior to that in the control group, but there is certain heterogeneity between the studies,so it is necessary to design large scale randomized controlled trial for verification.

Key words： Panax Notoginseng Saponins hip arthroplasty deep venous thrombosis(DVT) Meta analysis

Received: 26 October 2017

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Xu Jinlong
	Yao Lili
	Duan Baozhong
	Ma Weicheng

Cite this article:

Xu Jinlong,Yao Lili,Duan Baozhong, et al. Efficacy of Panax Notoginseng Saponins for deep venous thrombosis in hip arthroplasty: a Meta-analysis[J]. journal1, 2018, 25(2): 85-88.

URL:

http://manu58.magtech.com.cn/Jwk_zgyytj/EN/10.3969/j.issn.1006-5253.2018.02.002 OR http://manu58.magtech.com.cn/Jwk_zgyytj/EN/Y2018/V25/I2/85

[1] WOLF BR,LU X,LI Y,et a1.Adverse outcomes in hip arthroplasty:Long-term trends[J]. J Bone Joint Surg Am,2012,94(14) :1038.
[2] 马涛静.群组管理模式在髋关节置换术围手术期深静脉血栓预防中的应用[J].中国医院统计,2016,23(3):189-191.
[3] 中华医学会骨科学分会.中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2016,36(2):65-71.
[4] 王建民,曹立颖,杨声坪,等.阿哌沙班预防骨科大手术后静脉血栓栓塞的Meta分析[J].中华创伤杂志,2013,29(10):960-965.
[5] 郭梦园,崔向丽,刘丽宏.抗凝药物预防骨科大手术患者深静脉血栓形成的研究进展[J].中国临床药理学杂志,2016,32(16):1523-1526.
[6] 蒋科卫,温建民,毕春强,等.益气活血中药预防骨科大手术后深静脉血栓的临床观察[J].现代中医临床,2010,17(1):7-10.
[7] 张健,杨宇峰,杨晓阳.中医药在下肢深静脉血栓形成防治中的应用进展[J].中国医药指南,2013(1):70-71.
[8] 吴泽荣,庞瑞明,王明潮,等.三七粉预防全髋关节置换术后深静脉血栓形成的临床观察[J].中国伤残医学,2016,24(12):36-38.
[9] 印红兵.三七粉预防全髋关节置换术后下肢深静脉血栓形成的临床观察[J].山西中西,2016,32(9):43-44.
[10]蔡桦,李钊,邓森.中西药预防人工髋关节术后深静脉血栓形成的临床对照研究[J].中国矫形外科杂志,2011,19(19):1585-1588.
[11]李志友.中西药预防人工髋关节术后深静脉血栓形成的效果研究[J].中国当代医药,2014,21(13):61-63.
[12]刘会娟,耿树岩,王海涛.中西药预防下肢深静脉血栓形成血液流变学对比[J].中国矫形外科杂志,2015,23(9):856-858.
[13]耿树岩,刘会娟,王海涛.血塞通注射液预防下肢深静脉血栓疗效分析[C].临床医学专集,2015:1100-1101.
[14]周智,苏文杰.血栓通治疗全髋关节置换术后深静脉血栓60例临床观察[J].湖南中医杂志,2015,31(12):83-84
[15]甘雨,徐惠波,孙晓波. 三七总皂苷的药理作用研究进展[J].时珍国医国药,2007,18(5):1251-1252.